You are on page 1of 6

hrly until oral medication can be administered

         

Abdominal discomfort Intestinal cramps Nausea Vomiting Assess condition before therapy and reassess regularly there after to monitor drug’s effectiveness Monitor pt for anyadverse GI reactions,nausea,vomiting,diarrhea, Assess for adversereactions for pt. with hepaticencelopathy:regularly assessmental condition monitor I & O monitor for Inc.glucose level indiabetic pts

   Lactulose Duphalac


Inhibits bacterial DNA gyrase thus preventing replication insusceptible bacteria Constipation salmonellosis Treatmentof hepaticencephalopathy Pt who require alow lactose diet Galactosemia deficiency Intestinal obstruction

     


FORM: Syrup ROUTE: Oral DOSAGE: Adult:  PO Constipation Initial: 10-20 g

 

(15-30 mL)/day. Max: 45 mL (or 40 g of the reconstituted oral formulation)/day. Hepatic encephalopathy 60-100 g (90-150 mL)/day in 3 divided doses; adjust accordingly. Rectal Hepatic encephalopathy Mix 200 g (300 mL w/ 700 mL water or 0.9% NaCl as a retention enema. Retain enema for 30-60 mins; repeat 4-6

Consider IV rehydration in severe or prolonged diarrhoea. Maintain feeding during diarrhoea. Diabetes. resulting in a reducted secretion of water and electrolytes in the intestinal lumen Treatment of acute diarrhea. This leads to a reduction in cAMP mucosal levels. These enkephalins activate δ-opioid receptors in the GI tract. Rehydration. Not for acute dysentery w/ bloody stool & high fever. W/drawal of milk & dairy products. Powd Adjunct to oral or parenteralrehydration in the treatment of acute watery diarrhea in infants &children Powd Renal or hepatic impairment Fructose intolerance glucose &galactose malabsorption syndrome sucrase isomaltase deficiency INDICATION:   CONTRAINDICATION:     FORM:  powder . severe vomiting or food refusal. diarrhoea associated w/ broad-spectrum antibiot DOSAGE: SIDE EFFECTS:         GENERIC NAME:   Racecadotril Hidrasec BRAND NAME: ACTION:  NURSING INTEVENTION: Racecadotril increases the availability of endogenous opioids (enkephalins) by inhibiting the membrane-bound enkephalinase.ROUTE:   Oral Adult: PO 100 mg 3 times/day for ≤7 days Vomiting Nausea Constipation Abdominal pain Thirst Vertigo Headache Childn >24 mth.

e. myalgia. lactation Tablet PO Adult: PO 25–50 mg in 1–2 divided doses (max: 100 mg/d). headache. Musculoskeletal: Muscle cramps. on diuretics) CNS: Dizziness. & Drug Effects  Monitor BP at drug trough (prior to a scheduled dose). back or leg pain.Respiratory: Nasal congestion. cough. insomnia. INDICATION:   CONTRAINDICATION: FORM:    ROUTE: DOSAGE: SIDE EFFECTS:  . pregnancy [category C (first trimester). start with 25 mg/d if volume depleted (i. sinusitis..  Lab tests: Monitor CBC. dyspepsia. electrolytes. NURSING INTEVENTION: Assessment GENERIC NAME:    losartan potassium Cozaar BRAND NAME: ACTION: Angiotensin II receptor (type AT1) antagonist acts as a potent vasoconstrictor and primary vasoactive hormone of the renin– angiotensin–aldosterone system Hypertension Hypersensitivity to losartan. GI: Diarrhea.  Inadequate response may be improved by splitting the daily dose into twice-daily dose.  Monitor drug effectiveness. upper respiratory infection. especially in African-Americans when losartan is used as monotherapy. category D (second and third trimesters)]. liver & kidney function with longterm therapy.

bone & joint infections.75ml distilled water + 1. skin & skin structure infection. Hypersensitivity to lidocaine (IM inj) injection. UTI. powder. Treatment of infections of the lower resp tract.75ml 2% Lidocaine Pain Induration Phlebitis Rash Diarrhea Thrombocytosis Leucopenia Glossitis Respiratory superinfections       Assess patient’s previous sensitivity reaction to penicillin or other cephalosphorins. bacterial septicemia. Monitor hematologic. These enzymes are involved in cell-wall synthesis and cell division. uncomplicated gonorrhea. Assess for allergic reaction. malaise. meningitis. endopeptidases. Assess patient for signs and symptoms of infection before and during the treatment Obtain C&S before beginning drug therapy to identify if correct treatment has been initiated. pelvic inflammatory disease. acute bacterial otitis media. renal and hepatic function. redness. By binding to these enzymes.electrolytes. The beta-lactam moiety of Ceftriaxone binds to carboxypeptidases. Hypersensitivity to cephalosporins. for solution NURSING INTEVENTION: INDICATION:  CONTRAINDICATION:  FORM:  . and transpeptidases in the bacterial cytoplasmic membrane. Assess for possible superinfection: itching fever. intra-abdominal infections. diarhhea DOSAGE: SIDE EFFECTS: GENERIC NAME:    ceftriaxone Forgram          BRAND NAME: ACTION: Works by inhibiting the mucopeptide synthesis in the bacterial cell wall.ROUTE:   intramuscular 1 gram dissolve in 1 vial in 1. Ceftriaxone results in the formation of of defective cell walls and cell death.

jaundice. cirrhosis of liver. alone or in combination with other antihypertensive agents.  Lab tests: Obtain frequent blood count. Nausea. May be used for management of hypertension. increasing oliguria. Has been used concomitantly with mannitol for treatment of severe cerebral edema. and kidney disease. including nephrotic syndrome. (max: 480 mg/d) ROUTE: DOSAGE: GENERIC NAME:    Furosemide Lasix. closely monitor BP and vital signs. Sudden death from cardiac arrest has been reported. diarrhea. History of hypersensitivity to furosemide or sulfonamides. fluid and electrolyte depletion states. ampule Oral. hyperuricemia. acute hypotensive episodes. hearing loss (rarely permanent). lactation. pregnancy (category C). abdominal cramping. FORM:    Tablet. circulatory collapse. BUN. feeling of fullness in ears. CO2. particularly in meningitis. oral and gastric burning.  Monitor BP during periods of diuresis and through period of dosage adjustment. acute pancreatitis. serum and urine electrolytes. vomiting. Exact mode of action not clearly defined. blood sugar. elevated BUN. hepatic BRAND NAME: ACTION: SIDE EFFECTS:  INDICATION:  dizziness with excessive diuresis. blurred NURSING INTEVENTION: Assessment & Drug Effects  Observe patients receiving parenteral CONTRAINDICATION:  drug carefully. Intravenous Edema Adult: PO 20–80 mg in 1 or more divided doses up to 600 mg/d if needed IV/IM 20–40 mg in 1 or more divided doses up to 600 mg/d Hypertension Adult: PO 10–40 mg b.coma. and for treatment of hypercalcemia.i.  Observe older adults closely during period of brisk diuresis.d. Luramide Rapid-acting potent sulfonamide "loop" diuretic and antihypertensive with pharmacologic effects and uses almost identical to those of ethacrynic acid. dehydration. anorexia. and uric acid values during . hyponatremia hypokalemia. decreases renal vascular resistance and may increase renal blood flow Treatment of edema associated with CHF. anuria. constipation.

 Monitor urine and blood glucose & HbA1C closely in diabetics and patients with decompensated hepatic cirrhosis. Drug may cause hyperglycemia. Excessive diuresis can result in dehydration and hypovolemia.  Monitor I&O ratio and pattern. Weigh patient daily under standard conditions.  Monitor for S&S of hypokalemia. circulatory collapse. and hypotension.first few months of therapy and periodically thereafter. . Report decrease or unusual increase in output.